规范HIV感染者和艾滋病患者参与治疗,实现“90-90-90”战略目标

Standardizing HIV/AIDS Patients' Continuum of Engagement in Care,and Achieving " 90-90-90" Strategic Target

较高的持续参与治疗度可以降低艾滋病发病率、死亡率、疾病潜在传播风险、耐药性的发生以及治疗成本,但中国HIV感染者和艾滋病患者参与治疗现状尚不理想,其影响因素是多层级的,本文主要从患者相关因素、治疗相关因素、卫生保健体系相关因素以及社会与政策层面的因素进行分析。

Adequate continuum of engagement in AIDS care can decrease morbidity,mortality,potential risk of transmission,drug resistances and cost effectiveness of treatment. However, HIV/AIDS patients' continuum of engagement in care in China is unsatisfactory,its multilevel associated factors found by mainly include factors of patients themselves,treatment,the health care system,society and policy.